Department of Radiology, Massachusetts General Hospital, Harvard Medical School, White 270, 55 Fruit Street, White 270, Boston, MA, 02114, USA.
Department of Radiology, Gifu University, 1-1 Yanagido, Gifu, 501-1194, Japan.
Eur Radiol. 2021 Sep;31(9):6898-6908. doi: 10.1007/s00330-021-07744-w. Epub 2021 Mar 20.
To assess the feasibility of a proposed pancreatic protocol CT generated from portal-venous phase (PVP) dual-energy CT (DECT) acquisition and its impact on image quality, lesion conspicuity, and arterial visualization/involvement.
We included 111 patients (mean age, 66.8 years) who underwent pancreatic protocol DECT (pancreatic phase, PP, and PVP). The original DECT acquisition was used to create two data sets-standard protocol (50 keV PP/65 keV PVP) and proposed protocol (40 keV/65 keV PVP). Three reviewers evaluated the two data sets for image quality, lesion conspicuity, and arterial visualization/involvement using a 5-point scale. The signal-to-noise ratio (SNR) of pancreas and lesion-to-pancreas contrast-to-noise ratio (CNR) was calculated. Qualitative scores, quantitative parameters, and dose-length product (DLP) were compared between standard and proposed protocols.
The image quality, SNR of pancreas, and lesion-to-pancreas CNR of the standard and proposed protocol were comparable (p = 0.11-1.00). Lesion conspicuity was comparable between the standard and proposed protocols for pancreatic ductal adenocarcinoma (p = 0.55) and pancreatic cysts (p = 0.28). The visualization of larger arteries and arterial involvement were comparable between the two protocols (p = 0.056-1.00) while the scores were higher for smaller vessels in the standard protocol (p < 0.0001-0.0015). DLP of the proposed protocol (670.4 mGy·cm) showed a projected 42% reduction than the standard protocol (1145.9 mGy·cm) (p < 0.0001).
Pancreatic protocol CT generated from a single PVP DECT acquisition is feasible and could potentially be an alternative to the standard pancreatic protocol with PP and PVP.
• The lesion conspicuity for focal pancreatic lesions was comparable between the proposed protocol and standard dual-phase pancreatic protocol CT. • Qualitative and quantitative image assessments were almost comparable between two protocols. • The radiation dose of a proposed protocol showed a projected 42% reduction from the conventional protocol.
评估从门静脉期(PVP)双能 CT(DECT)采集生成拟议胰腺方案 CT 的可行性及其对图像质量、病灶显影和动脉可视化/受累的影响。
我们纳入了 111 例患者(平均年龄 66.8 岁),他们接受了胰腺方案 DECT(胰腺期,PP 和 PVP)检查。使用原始 DECT 采集创建了两个数据集-标准方案(50keV PP/65keV PVP)和拟议方案(40keV/65keV PVP)。三位审阅者使用 5 分制评估了两个数据集的图像质量、病灶显影和动脉可视化/受累情况。计算胰腺的信噪比(SNR)和病灶-胰腺对比噪声比(CNR)。比较了标准和拟议方案之间的定性评分、定量参数和剂量长度乘积(DLP)。
标准和拟议方案的图像质量、胰腺 SNR 和病灶-胰腺 CNR 相当(p=0.11-1.00)。标准和拟议方案中胰腺导管腺癌(p=0.55)和胰腺囊肿(p=0.28)的病灶显影相当。较大动脉的可视化和动脉受累情况在两个方案之间相当(p=0.056-1.00),而标准方案中小血管的评分更高(p<0.0001-0.0015)。拟议方案的 DLP(670.4mGy·cm)比标准方案(1145.9mGy·cm)预计减少 42%(p<0.0001)。
从门静脉期 DECT 采集生成的胰腺方案 CT 是可行的,可能是具有胰腺期和门静脉期的标准胰腺方案 CT 的替代方案。
拟议方案与标准双期胰腺方案 CT 相比,局灶性胰腺病变的病灶显影相当。
两个方案的定性和定量评估几乎相当。
拟议方案的辐射剂量预计比常规方案减少 42%。